- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Sibel Blau Discusses Technology Challenges and Data Sharing
The electronic medical record (EMR) can be burdensome but having a good value-based care team collecting data can help, said Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
The electronic medical record (EMR) can be burdensome but having a good value-based care team collecting data can help, said Sibel Blau, MD, medical oncologist at Northwest Medical Specialties, PLLC.
Transcript
What have been some of the challenges you face with technology and data sharing?
There is a need to put as much structured data as possible, predetermined by workers on creating the EMR and working with them on how we need that information to be put in. So, we use OncoEMR, and it’s structured data requires a lot of clicks in the boxes and a lot of remembrance from anybody whose touching the EMR. Anybody from the front desk to the back office to the providers. Nurses, of course, they have to do their piece.
So, it requires much longer and more work in the EMR and that is one piece that has been very overwhelming, and that cause a lot of physician burnout on our part.
The other thing is, of course, data sharing. Now that piece, we have a very good value-based care team; the head of it, Amy Ellis, and the team, the [information technology] team at Northwest Medical Specialties, has actually done a very smooth job on collecting the data and sharing it. Of course, it’s a lot of work, but I don’t think it was as burdensome as what we had gone through prior to putting all that data into the EMR.
Managed Care Cast Presents: BTK Inhibitors in Treatment-Naive Patients With CLL and MCL
December 26th 2024A trio of experts discuss the treatment of chronic lymphocytic leukemia (CLL) and mantle cell lymphoma (MCL) with Bruton tyrosine kinase (BTK) inhibitors, including cost considerations.
Listen
HS Treatment Goals: Better Quality of Life, Not Just Control
January 3rd 2025For part 3 of our discussion with Chris Sayed, MD, we tackle several important topics in the hidradenitis suppurative (HS) and inflammatory disease space: patient quality of life, medication and treatment goals, and the possibility of a cure.
Read More
Dr Yehuda Handelsman: DCRM Guidelines Are Shaping Integrated, Global CRM Care
January 3rd 2025In part 2 of our interview, Yehuda Handelsman, MD, discusses how cardiorenalmetabolic (CRM) disease management is advancing with the 2022 Diabetes, Cardiorenal, and Metabolic (DCRM) multispecialty practice recommendations and the updated DCRM 2.0 guidelines.
Read More
Stripped of Fucose, Powerful Monoclonal Antibody Shows Promising Results in MDS Dosing Study
January 2nd 2025Nicole Grieselhuber, MD, PhD, of The Ohio State University, discusses results from Part D of a dosing study involving patients with previously untreated higher-risk myelodysplastic syndrome (MDS) who were treated with a combination of SEA-CD70 and azacitidine.
Read More
